Vero, Vittoria
 Distribuzione geografica
Continente #
EU - Europa 902
NA - Nord America 663
AS - Asia 142
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.714
Nazione #
US - Stati Uniti d'America 660
DE - Germania 470
SE - Svezia 155
CN - Cina 105
UA - Ucraina 92
IE - Irlanda 51
FI - Finlandia 31
FR - Francia 28
IT - Italia 23
GB - Regno Unito 21
TR - Turchia 19
BE - Belgio 16
IN - India 10
RU - Federazione Russa 9
JP - Giappone 5
RO - Romania 4
IR - Iran 3
AU - Australia 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BZ - Belize 1
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EU - Europa 1
HR - Croazia 1
MX - Messico 1
Totale 1.714
Città #
Chandler 153
Jacksonville 57
Dublin 50
San Mateo 39
Nanjing 37
Chicago 36
Nürnberg 27
Dearborn 24
Wilmington 23
Boston 20
Munich 20
Izmir 19
Marseille 19
Ashburn 17
Brussels 16
Ann Arbor 14
Helsinki 14
Houston 13
Princeton 13
Nanchang 12
Woodbridge 9
Redwood City 8
Beijing 6
Detroit 6
Mountain View 6
Norwalk 6
San Diego 6
University Park 6
Bremen 5
Hebei 5
Kunming 5
Lawrence 5
San Jose 5
Seattle 5
Shenyang 5
Changsha 4
Fairfield 4
Fremont 4
Guangzhou 4
Hefei 4
Portland 4
Tianjin 4
Boardman 3
Jiaxing 3
Jinan 3
Milan 3
New York 3
Andover 2
Cattolica 2
Clayton 2
Como 2
Hangzhou 2
Kish 2
Leawood 2
Ningbo 2
Orangeburg 2
Saint-Pierre 2
Shanghai 2
Simi Valley 2
Verona 2
Abidjan 1
Adliswil 1
Ardabil 1
Belize City 1
Boydton 1
Chengdu 1
Costa Mesa 1
Dalmine 1
Garza García 1
Gunzenhausen 1
Indiana 1
Jian 1
Lanzhou 1
Markdorf 1
Philadelphia 1
Phoenix 1
Rome 1
Sacramento 1
Saint Louis 1
Serra Pedace 1
Shaoxing 1
Sibiu 1
Taizhou 1
Thornhill 1
Tokyo 1
Vancouver 1
Walnut 1
Zagreb 1
Zhengzhou 1
Zhongxin 1
Totale 810
Nome #
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 153
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 143
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 135
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 110
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 98
gastroesophageal reflux disease: facts and uncertaines 96
[The treatment of hepatocellular carcinoma: an update] 96
-Fatty liver and drugs 91
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 90
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 75
-Nonalcoholic fatty liver disease: defining a common problem 75
Braised liver with herbs: the risks of naturopathic hepatoprotection. 73
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 71
The EFSA health claims 'learning experience' 67
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 64
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 62
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 56
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 50
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 27
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 23
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 16
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 15
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 11
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 11
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 10
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 10
Totale 1.728
Categoria #
all - tutte 4.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019182 0 0 0 1 34 27 25 12 10 18 32 23
2019/2020248 47 11 12 15 22 34 29 8 14 16 15 25
2020/2021166 6 19 1 18 30 7 17 1 30 0 27 10
2021/2022179 4 24 1 18 11 4 2 26 5 7 40 37
2022/2023489 44 57 29 60 43 55 32 41 64 39 16 9
2023/202494 15 77 2 0 0 0 0 0 0 0 0 0
Totale 1.728